The Yi–Xin–Shu (YXS) capsule, a drug suggested by traditional Chinese medicine (TCM), is commonly applied in the treatment of cardiac hypertrophy by regulating the expression of GATA4, HDAC1, and retinoblastoma (RB) and the corresponding signalling pathway. This evidence concerns the gene HDAC1 and cardiac hypertrophy.